PeptX supplies Retatrutide (LY3437943), Eli Lilly's investigational GLP-1, GIP and glucagon receptor triple agonist, to Canadian research laboratories and group-buy collectives. manufacturer-stated 99%+ purity, tracked Canada-wide delivery, transparent USD pricing with live CAD conversion. Strictly for in-vitro laboratory research, not for human or animal consumption.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.